当前位置: X-MOL 学术J. Biomed. Nanotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Facile Ultrasound-Triggered Release of Calcein and Doxorubicin from Iron-Based Metal-Organic Frameworks.
Journal of Biomedical Nanotechnology Pub Date : 2021-1-10 , DOI: 10.1166/jbn.2020.2972
Mihad Ibrahim , Rana Sabouni , Ghaleb A. Husseini , Abdollah Karami , Renu Geetha Bai , Debasmita Mukhopadhyay

Metal-organic frameworks (MOFs) are promising new nanocarriers with potential use in anticancer drug delivery. However, there is a scarcity of studies on the uptake and release of guest molecules associated with MOF nanovehicles, and their mechanism is poorly understood. In this work, newly developed iron-based MOFs, namely Fe-NDC nanorods, were investigated as potential nanocarriers for calcein (as a model drug/dye) and Doxorubicin (a chemotherapeutic drug (DOX)). Calcein was successfully loaded by equilibrating its solution with the MOFs nanoparticles under constant stirring. The calcein average encapsulation efficiency achieved was 43.13%, with a corresponding capacity of 17.74 wt.%. In-vitro calcein release was then carried out at 37°C in phosphate buffer saline (PBS) using ultrasound (US) as an external trigger. MOFs released an average of 17.8% (without US), whereas they released up to 95.2% of their contents when 40-kHz US at ~1 W/cm² was applied for 10 min. The Cytotoxic drug DOX was also encapsulated in Fe-NDC, and its In-vitro release profile was determined under the same conditions. DOX encapsulation efficiency and capacity were found to be 16.10% and 13.37 wt.%, respectively. In-vitro release experiments demonstrated significant release, reaching 80% in 245 minutes, under acoustic irradiation, compared to around 6% in the absence of US. Additionally, experimental results showed that Fe-NDC nanoparticles are biocompatible even at relatively high concentrations, with an MCF-7 IC50 of 1022 g/ml. Our work provides a promising platform for anticancer drug delivery by utilizing biocompatible Fe-NDC nanoparticles and US as an external trigger mechanism.

中文翻译:

从铁基金属有机框架中轻松触发超声触发钙黄绿素和阿霉素的释放。

金属有机框架(MOF)是有前途的新型纳米载体,具有潜在的抗癌药物递送用途。然而,关于与MOF纳米车辆相关的客体分子的摄取和释放的研究很少,其机理尚不清楚。在这项工作中,研究了新开发的铁基MOF,即Fe-NDC纳米棒,作为钙黄绿素(作为模型药物/染料)和阿霉素(化学治疗药物(DOX))的潜在纳米载体。通过在不断搅拌下用MOFs纳米颗粒平衡其溶液来成功加载钙黄绿素。钙黄绿素的平均包封效率为43.13%,相应的容量为17.74 wt。%。然后在37°C的磷酸盐缓冲液(PBS)中使用超声(US)作为外部触发剂进行体外钙黄绿素的释放。财政部平均发布了17。8%(不含US),而当以〜1 W /cm²的40 kHz US施加10分钟时,它们释放的含量高达95.2%。细胞毒性药物DOX也被封装在Fe-NDC中,并在相同条件下测定了其体外释放曲线。发现DOX的包封效率和容量分别为16.10%和13.37重量%。体外释放实验表明,在声辐射下,释放显着释放,在245分钟内达到80%,而在没有US的情况下,释放约达到6%。此外,实验结果表明,即使在相对较高的浓度下,Fe-NDC纳米颗粒也具有生物相容性,MCF-7 IC 50为1022 g / ml。我们的工作通过利用生物相容的Fe-NDC纳米颗粒和US作为外部触发机制,为抗癌药物的输送提供了一个有希望的平台。
更新日期:2021-01-11
down
wechat
bug